Hedge Fund - Wynnefield Capital

Lifecore Biomedical Inc. (LFCR) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q2 (2025-06-30) $38,190,113 22.53% 4,703,216 $6.74
2 2025 - Q1 (2025-03-31) $33,110,640 20.95% 4,703,216 $6.21
3 2024 - Q4 (2024-12-31) $34,944,894 15.92% 4,703,216 $6.39
4 2024 - Q3 (2024-09-30) $24,250,566 10.79% 4,918,979 $5.22
5 2024 - Q2 (2024-06-30) $25,234,362 11.34% 4,918,979 $5.92
6 2024 - Q1 (2024-03-31) $26,144,024 10.38% 4,923,545 $7.15
7 2023 - Q4 (2023-12-31) $30,476,744 11.78% 4,923,545 $6.94
8 2023 - Q3 (2023-09-30) $37,148,147 17.04% 4,923,545 $9.14
9 2023 - Q2 (2023-06-30) $47,610,680 23.8% 4,923,545 $6.11
10 2023 - Q1 (2023-03-31) $18,586,382 12.03% 4,923,545 $5.57
11 2022 - Q4 (2022-12-31) $28,917,065 16.63% 4,462,510 $8.24
12 2022 - Q3 (2022-09-30) $31,411,000 16.56% 3,533,287 $10.17
13 2022 - Q2 (2022-06-30) $35,227,000 17.8% 3,533,287 $9.90
14 2022 - Q1 (2022-03-31) $40,915,000 15.61% 3,533,287 $11.14
15 2021 - Q4 (2021-12-31) $34,919,000 12.46% 3,145,887 $9.70
16 2021 - Q3 (2021-09-30) $29,005,000 15.66% 3,145,887 $10.88
17 2021 - Q2 (2021-06-30) $35,391,000 16.31% 3,145,887 $11.53
18 2021 - Q1 (2021-03-31) $30,651,000 15.27% 2,905,300 $11.24
19 2020 - Q4 (2020-12-31) $31,306,000 15.82% 2,885,300 $10.33
20 2020 - Q3 (2020-09-30) $27,948,000 17.39% 2,875,300 $9.52
21 2020 - Q2 (2020-06-30) $22,887,000 16.86% 2,875,300 $10.32
22 2020 - Q1 (2020-03-31) $24,943,000 23.65% 2,870,300 $10.41
23 2019 - Q4 (2019-12-31) $32,463,000 21.66% 2,870,300 $10.64
24 2019 - Q3 (2019-09-30) $31,200,000 16.6% 2,870,300 $10.89
25 2019 - Q2 (2019-06-30) $26,192,000 13.42% 2,795,300 $10.09
26 2019 - Q1 (2019-03-31) $33,590,000 15.95% 2,735,300 $12.21
27 2018 - Q4 (2018-12-31) $31,759,000 16.1% 2,682,400 $13.73
28 2018 - Q3 (2018-09-30) $38,627,000 16.11% 2,682,400 $13.83
29 2018 - Q2 (2018-06-30) $39,968,000 14.75% 2,682,400 $13.90
30 2018 - Q1 (2018-03-31) $35,005,000 12.17% 2,682,400 $13.14
31 2017 - Q4 (2017-12-31) $33,798,000 11.66% 2,682,400 $12.64
32 2017 - Q3 (2017-09-30) $34,737,000 12.42% 2,682,400 $13.18
33 2017 - Q2 (2017-06-30) $39,833,000 13.28% 2,682,400 $13.92
34 2017 - Q1 (2017-03-31) $32,188,000 11.79% 2,682,400 $12.66
35 2016 - Q4 (2016-12-31) $37,016,000 13.33% 2,682,400 $13.85
36 2016 - Q3 (2016-09-30) $35,970,000 12.03% 2,682,400 $12.11
37 2016 - Q2 (2016-06-30) $28,863,000 10.44% 2,682,400 $11.03
38 2016 - Q1 (2016-03-31) $28,165,000 11.06% 2,682,400 $10.98
39 2015 - Q4 (2015-12-31) $31,732,000 10.72% 2,682,400 $12.28
40 2015 - Q3 (2015-09-30) $31,101,000 12.45% 2,665,000 $13.25
41 2015 - Q2 (2015-06-30) $38,239,000 14.72% 2,650,000 $14.43
42 2015 - Q1 (2015-03-31) $36,967,000 16.33% 2,650,000 $13.82
43 2014 - Q4 (2014-12-31) $36,596,000 15.51% 2,650,000 $12.92
44 2014 - Q3 (2014-09-30) $30,039,000 13.89% 2,630,000 $12.48
45 2014 - Q2 (2014-06-30) $21,412,000 9.86% 1,714,400 $11.77
46 2014 - Q1 (2014-03-31) $19,132,000 9.34% 1,714,400 $10.97
47 2013 - Q4 (2013-12-31) $19,141,000 8.57% 1,637,986 $11.94
48 2013 - Q3 (2013-09-30) $19,156,000 7.22% 1,637,986 $13.95
49 2013 - Q2 (2013-06-30) $22,853,000 8.58% 1,802,801 $13.83
50 2013 - Q1 (2013-03-31) $27,344,000 9.31% 1,964,700 $11.79
51 2012 - Q4 (2012-12-31) $19,781,000 6.87% 2,172,260 $10.05
52 2012 - Q3 (2012-09-30) $24,057,000 8.77% 2,193,271 $9.37
53 2012 - Q1 (2012-03-31) $16,005,000 5.59% 2,568,271 $6.31
54 2011 - Q4 (2011-12-31) $14,156,000 5.48% 2,564,524 $5.63
55 2011 - Q3 (2011-09-30) $12,665,000 5.37% 2,497,924 $6.06
56 2011 - Q2 (2011-06-30) $12,930,000 4.75% 2,012,714 $6.05
57 2011 - Q1 (2011-03-31) $10,055,000 4.84% 1,587,500 $6.30
58 2010 - Q4 (2010-12-31) $7,365,000 3.61% 1,247,218 $6.21

The displayed share prices are average quarterly stock market prices.